NCT07038369 2026-03-17A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsAtavistik Bio, IncPhase 1 Active not recruiting134 enrolled
NCT06533059 2026-03-09A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid TumorsAlterome Therapeutics, Inc.Phase 1 Recruiting110 enrolled
NCT05617755 2025-07-30AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian CancerArsenal Biosciences, Inc.Phase 1 Active not recruiting19 enrolled
NCT02164461 2024-05-20Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical CancerAdvaxis, Inc.Phase 1 Completed12 enrolled 18 charts
NCT02978755 2022-04-06First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological CancersGamaMabs PharmaPhase 1 Completed78 enrolled
NCT03101280 2020-10-22A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast CancerHoffmann-La RochePhase 1 Completed29 enrolled
NCT00749502 2013-07-25A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)Tesaro, Inc.Phase 1 Completed113 enrolled